SHARE-BASED COMPENSATION (Tables)
|
9 Months Ended |
Aug. 02, 2026 |
| SHARE-BASED COMPENSATION [Abstract] |
|
| Share-based Compensation Expenses |
The table below presents information on the Company’s share-based compensation expenses.
| |
| | | |
| | | |
| | | |
| | | |
| |
| Three Months Ended | |
| Nine Months Ended | |
| |
|
August 2, 2026
| |
|
August 3, 2025
| |
|
August 2, 2026
| |
|
August 3, 2025
| |
| |
|
Expense reported in:
|
| | | |
| | | |
| | | |
| | | |
|
Cost of goods sold
|
| $ | 977 | |
| $ | 816 | |
| $ | 2,801 | |
| $ | 2,378 | |
|
Selling, general, and administrative
|
| | 2,729 | |
| | 2,174 | |
| | 7,869 | |
| | 6,729 | |
|
Research and development
|
| | 155 | |
| | 304 | |
| | (233 | ) |
| | 896 | |
|
Total expense incurred
|
| $ | 3,861 | |
| $ | 3,294 | |
| $ | 10,437 | |
| $ | 10,003 | |
| |
| | | |
| | | |
| | | |
| | | |
|
Expense by award type:
|
| | | |
| | | |
| | | |
| | | |
|
Restricted stock awards
|
| $ | 2,275 | |
| $ | 2,943 | |
| $ | 6,516 | |
| $ | 9,029 | |
|
Restricted stock units
|
| | 1,547 | |
| | 294 | |
| | 3,806 | |
| | 803 | |
|
Employee stock purchase plan
|
| | 39 | |
| | 57 | |
| | 115 | |
| | 171 | |
|
Total expense incurred
|
| $ | 3,861 | |
| $ | 3,294 | |
| $ | 10,437 | |
| $ | 10,003 | |
| |
| | | |
| | | |
| | | |
| | | |
|
Income tax benefits on share-based compensation
|
| $ | 787 | |
| $ | 461 | |
| $ | 2,149 | |
| $ | 1,313 | |
|
| Restricted Stock Awards Activity |
The table below presents information
on the Company’s restricted stock awards. | | | | | | | | | | | | | | | | | | | |
| Three Months Ended | |
| Nine Months Ended | | | | | August 2, 2026 | | | August 3, 2025 | | | August 2, 2026 | | | August 3, 2025 | | | Number of shares granted in period | | | - | | | | - | | | | - | | | | 583,238 | | | Weighted-average grant-date fair value of awards (in dollars per share) | | $ | - | | | $ | - | | | $ | - | | | $ | 23.42 | | | Compensation cost not yet recognized | | $ | 13,256 | | | $ | 24,414 | | | $ | 13,256 | | | $ | 24,414 | | | Weighted-average amortization period for cost not yet recognized (in years) | | | 2.0 | | | | 2.8 | | | | 2.0 | | | | 2.8 | | | Restricted shares outstanding at balance sheet date | | | 800,761 | | | | 1,421,897 | | | | 800,761 | | | | 1,421,897 | |
|
| Restricted Stock Units Activity |
The table below presents information on the Company’s restricted stock unit awards. | | | | | | | | | | | | | | | | | | | |
| Three Months Ended | |
| Nine Months Ended | | | | | | August 2, 2026 | | | | August 3, 2025 | | | | August 2, 2026 | | | | August 3, 2025 | | | Number of units granted in period | | | 10,021 | | | | 109,830 | | | | 599,622 | | | | 162,666 | | | Weighted-average grant-date fair value of awards (in dollars per share) | | $ | 28.94 | | | $ | 18.21 | | | $ | 33.91 | | | $ | 19.61 | | | Compensation cost not yet recognized | | $ | 15,940 | | | $ | 2,387 | | | $ | 15,940 | | | $ | 2,387 | | | Weighted-average amortization period for cost not yet recognized (in years) | | | 3.3 | | | | 3.3 | | | | 3.3 | | | | 3.3 | | | Restricted stock units outstanding at balance sheet date | | | 650,171 | | | | 132,474 | | | | 650,171 | | | | 132,474 | |
|
| Stock Options Activity |
The
table below presents information on the Company’s stock options.
| | | | | | | | | | | | | | | | |
| |
| Three Months Ended | |
| Nine Months Ended | |
| |
|
August 2,
2026
| |
|
August 3,
2025
| |
|
August 2,
2026
| |
|
August 3,
2025
| |
|
Number
of options granted in period
|
| | - | |
| | - | |
| | - | |
| | - | |
|
Cash
received from options exercised
|
| $ | 9 | |
| $ | 400 | |
| $ | 1,001 | |
| $ | 1,698 | |
|
Compensation
cost not yet recognized
|
| $ | - | |
| $ | - | |
| $ | - | |
| $ | - | |
|
Weighted-average
amortization period for cost not yet recognized (in years)
|
| | - | |
| | - | |
| | - | |
| | - | |
|
| Outstanding and Exercisable Option |
Information regarding outstanding and exercisable option awards as of August 2, 2026, is presented below. | | | | | | | | | | | | | | | | | | Options | | | Shares | | | |
Weighted Average Exercise Price
| | | |
Weighted Average Remaining Contractual Life (in years) | | | |
Aggregate Intrinsic Value | | | Outstanding and exercisable at August 2, 2026 | | | 18,250 | | | $ | 9.56 | | | | 1.55 | | | $ | 378 | |
|